Product: Octreotide Acetate Injection 50 mcg/mL, 1 mL single-dose vial, Rx only, Teva Pharmaceuticals USA. Inc. North Wales, PA 19454, NDC 0703-3301-01
Reason for recall: Lack of Assurance of Sterility
Recall initiated: 20210729
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated